14 results
10-K
2020 FY
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Annual report
8:33am
technical, financial and human resources. If we are unable to identify suitable compounds for preclinical and clinical development, we will not be able … or with their strategic partners, have:
greater financial, technical and human resources than we have at every stage of the discovery, development, manufacture
10-K
2020 FY
EX-10.3
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Annual report
8:33am
, by contacting his or her local human resources representative. The Company may cancel Participant’s ability to participate in the Plan and, in the Board’s … . For more information on the consequences of refusal to consent or withdrawal of consent, Participants may contact their local human resources representative
10-Q
y0w3r
23 Nov 20
Quarterly report
4:16pm
424B4
0bxzf9oi
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1/A
c60yn1 mny107j5yt
9 Oct 20
IPO registration (amended)
6:09am
S-1
EX-10.3
ep2 zrpllyrt1o65
25 Sep 20
IPO registration
5:19pm
S-1
sdyxb245q6e9nzf
25 Sep 20
IPO registration
5:19pm
DRS/A
q2js0dcs
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
0u1uc5m237we87a
22 Jul 20
Draft registration statement
12:00am
DRS
EX-10.3
p1orejh0xreikwif23
22 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next